 AIM: test hypothesis fluid resuscitation Ringer's solution enriched pyruvate (PR), physiological antioxidant energy substrate, affords protection myocardial metabolism electrophysiological performance superior lactated Ringer's (LR) hypovolemia hindlimb ischemia-reperfusion. METHODS: Male domestic goats (25-30 kg) exsanguinated mean arterial pressure 48 +/- 1 mmHg. Right hindlimb ischemia imposed 90 min applying tourniquet femoral crossclamp. LR PR, infused iv, delivered 0.05 mmol/kg per minute L-lactate pyruvate, respectively, 30 min hindlimb ischemia 30 min post-ischemia. Time controls (TC) underwent neither hemorrhage, hindlimb ischemia resuscitation. Goats sacrificed left ventricular myocardium biopsied 90 min fluid resuscitation (n = 6 per group) 3.5 h later (n = 9 LR, 10 PR, 8 TC). RESULTS: Myocardial 8-isoprostane content, phosphocreatine phosphorylation potential, creatine kinase activity, heart rate-adjusted QT interval (QTc) variability evaluated 90 min resuscitation 3.5 h post-resuscitation. PR sharply lowered pro-arrhythmic QTc variability vs LR (P < 0.05); effect persisted 3.5 h post-resuscitation. PR lowered myocardial 8-isoprostane content, product oxidative stress, 39 37% 3.5 h resuscitation, respectively, vs LR. Creatine kinase activity fell 42% post-LR vs TC (P < 0.05), stable post-PR (P < 0.02 vs post-LR). PR doubled phosphocreatine phosphorylation potential, measure ATP free energy state, vs TC LR (P < 0.05); energetic enhancement persisted 3.5 h post-resuscitation. CONCLUSION: augmenting myocardial energy state protecting creatine kinase activity, pyruvate-enriched resuscitation stabilized cardiac electrical function central hypovolemia hindlimb ischemia-reperfusion.